Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids
Kathryn A. Seely, Jeff Lapoint, Jeffery H. Moran, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2012) Vol. 39, Iss. 2, pp. 234-243
Open Access | Times Cited: 455

Showing 1-25 of 455 citing articles:

Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations
Benedikt Fischer, Cayley Russell, Pamela Sabioni, et al.
American Journal of Public Health (2017) Vol. 107, Iss. 8, pp. e1-e12
Open Access | Times Cited: 364
A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment
Robert J. Tait, David Caldicott, David Mountain, et al.
Clinical Toxicology (2015) Vol. 54, Iss. 1, pp. 1-13
Open Access | Times Cited: 354
Gone to Pot – A Review of the Association between Cannabis and Psychosis
Rajiv Radhakrishnan, Samuel T. Wilkinson, Deepak Cyril Dâ€TMSouza
Frontiers in Psychiatry (2014) Vol. 5
Open Access | Times Cited: 281
Spicing things up: synthetic cannabinoids
Max Spaderna, Peter H. Addy, Deepak Cyril D’Souza
Psychopharmacology (2013) Vol. 228, Iss. 4, pp. 525-540
Open Access | Times Cited: 277
The hallucinogenic world of tryptamines: an updated review
Ana Margarida Araújo, Félix Carvalho, Maria de Lourdes Bastos, et al.
Archives of Toxicology (2015) Vol. 89, Iss. 8, pp. 1151-1173
Closed Access | Times Cited: 257
Measuring biomarkers in wastewater as a new source of epidemiological information: Current state and future perspectives
Emma Gracia‐Lor, Sara Castiglioni, Richard Bade, et al.
Environment International (2016) Vol. 99, pp. 131-150
Open Access | Times Cited: 257
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity?
William E. Fantegrossi, Jeffery H. Moran, Anna Radomińska‐Pandya, et al.
Life Sciences (2013) Vol. 97, Iss. 1, pp. 45-54
Open Access | Times Cited: 251
Traditional marijuana, high‐potency cannabis and synthetic cannabinoids: increasing risk for psychosis
Robin M. Murray, Harriet Quigley, Diego Quattrone, et al.
World Psychiatry (2016) Vol. 15, Iss. 3, pp. 195-204
Open Access | Times Cited: 249
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects
Jan van Amsterdam, Tibor M. Brunt, Wim van den Brink
Journal of Psychopharmacology (2015) Vol. 29, Iss. 3, pp. 254-263
Closed Access | Times Cited: 231
Patterns of synthetic cannabinoid use in Australia
Monica J. Barratt, Vince Cakic, Simon Lenton
Drug and Alcohol Review (2012) Vol. 32, Iss. 2, pp. 141-146
Open Access | Times Cited: 217
Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay
Annelies Cannaert, Jolien Storme, Florian Franz, et al.
Analytical Chemistry (2016) Vol. 88, Iss. 23, pp. 11476-11485
Open Access | Times Cited: 211
Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health
Aviv Weinstein, Paola Rosca, Liana Fattore, et al.
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 181
Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands
Krishna C. Chimalakonda, Kathryn A. Seely, Stacie M. Bratton, et al.
Drug Metabolism and Disposition (2012) Vol. 40, Iss. 11, pp. 2174-2184
Open Access | Times Cited: 183
Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective
Koby Cohen, Aviv Weinstein
Frontiers in Public Health (2018) Vol. 6
Open Access | Times Cited: 154
Synthetic Cannabinoids—Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis
Liana Fattore
Biological Psychiatry (2016) Vol. 79, Iss. 7, pp. 539-548
Closed Access | Times Cited: 147
Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines
Michael H. Baumann, Ernesto Solis, Lucas R. Watterson, et al.
Journal of Neuroscience (2014) Vol. 34, Iss. 46, pp. 15150-15158
Open Access | Times Cited: 145
The Structure–Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation
Eric W. Bow, John M. Rimoldi
Perspectives in Medicinal Chemistry (2016) Vol. 8
Open Access | Times Cited: 135
Ischemic stroke after use of the synthetic marijuana “spice”
Melissa Freeman, David Z. Rose, Martin Myers, et al.
Neurology (2013) Vol. 81, Iss. 24, pp. 2090-2093
Open Access | Times Cited: 132
Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry
Karl B. Scheidweiler, Michael J. Y. Jarvis, Marilyn A. Huestis
Analytical and Bioanalytical Chemistry (2014) Vol. 407, Iss. 3, pp. 883-897
Closed Access | Times Cited: 130
Toxicological Findings of Synthetic Cannabinoids in Recreational Users
Robert Kronstrand, Mabel Jouve, Mikael Andersson, et al.
Journal of Analytical Toxicology (2013) Vol. 37, Iss. 8, pp. 534-541
Open Access | Times Cited: 126
Synthetic cannabinoid use among patients in residential substance use disorder treatment: Prevalence, motives, and correlates
Erin E. Bonar, Lisham Ashrafioun, Mark A. Ilgen
Drug and Alcohol Dependence (2014) Vol. 143, pp. 268-271
Open Access | Times Cited: 124
A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse
Aristides Tsatsakis, Anca Oana Docea, Daniela Călina, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 9, pp. 1295-1295
Open Access | Times Cited: 123
Driving under the influence of synthetic cannabinoids (“Spice”): a case series
Frank Mußhoff, Burkhard Madea, Gerhard Kernbach‐Wighton, et al.
International Journal of Legal Medicine (2013) Vol. 128, Iss. 1, pp. 59-64
Closed Access | Times Cited: 121
Detection of new psychoactive substance use among emergency room patients: Results from the Swedish STRIDA project
Anders Helander, Matilda Bäckberg, Peter Hultén, et al.
Forensic Science International (2014) Vol. 243, pp. 23-29
Closed Access | Times Cited: 121
Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample
Adam Winstock, Michael T. Lynskey, Rohan Borschmann, et al.
Journal of Psychopharmacology (2015) Vol. 29, Iss. 6, pp. 698-703
Closed Access | Times Cited: 113
Page 1 - Next Page

Scroll to top